391 related articles for article (PubMed ID: 29858247)
1. Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes.
Fong LK; Yang MM; Dos Santos Chaves R; Reyna SM; Langness VF; Woodruff G; Roberts EA; Young JE; Goldstein LSB
J Biol Chem; 2018 Jul; 293(29):11341-11357. PubMed ID: 29858247
[TBL] [Abstract][Full Text] [Related]
2. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease.
Marzolo MP; Bu G
Semin Cell Dev Biol; 2009 Apr; 20(2):191-200. PubMed ID: 19041409
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization.
Langness VF; van der Kant R; Das U; Wang L; Chaves RDS; Goldstein LSB
Mol Biol Cell; 2021 Feb; 32(3):247-259. PubMed ID: 33296223
[TBL] [Abstract][Full Text] [Related]
6. Effects of cholesterol transport inhibitor U18666A on APP metabolism in rat primary astrocytes.
Yang H; Wang Y; Kar S
Glia; 2017 Nov; 65(11):1728-1743. PubMed ID: 28722194
[TBL] [Abstract][Full Text] [Related]
7. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation.
Lee SI; Jeong W; Lim H; Cho S; Lee H; Jang Y; Cho J; Bae S; Lin YT; Tsai LH; Moon DW; Seo J
Stem Cell Reports; 2021 Sep; 16(9):2128-2137. PubMed ID: 34450034
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein α- and β-cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2.
Wang W; Mutka AL; Zmrzljak UP; Rozman D; Tanila H; Gylling H; Remes AM; Huttunen HJ; Ikonen E
FASEB J; 2014 Feb; 28(2):849-60. PubMed ID: 24249638
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes.
Arnst N; Belio-Mairal P; García-González L; Arnaud L; Greetham L; Nivet E; Rivera S; Dityatev A
Cells; 2021 Jul; 10(7):. PubMed ID: 34359875
[TBL] [Abstract][Full Text] [Related]
10. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
11. Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations.
Woodruff G; Reyna SM; Dunlap M; Van Der Kant R; Callender JA; Young JE; Roberts EA; Goldstein LS
Cell Rep; 2016 Oct; 17(3):759-773. PubMed ID: 27732852
[TBL] [Abstract][Full Text] [Related]
12. Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein.
Seki T; Kanagawa M; Kobayashi K; Kowa H; Yahata N; Maruyama K; Iwata N; Inoue H; Toda T
J Biol Chem; 2020 Mar; 295(11):3678-3691. PubMed ID: 31996371
[TBL] [Abstract][Full Text] [Related]
13. Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in Vitro.
Hou H; Habib A; Zi D; Tian K; Tian J; Giunta B; Sawmiller D; Tan J
Neuromolecular Med; 2017 Sep; 19(2-3):300-308. PubMed ID: 28612181
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases.
Wang Y; Li M; Tang J; Song M; Xu X; Xiong J; Li J; Bai Y
Endocrinology; 2011 Jul; 152(7):2704-15. PubMed ID: 21558319
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
[TBL] [Abstract][Full Text] [Related]
16. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
17. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
19. Role of amyloid beta in lipid homeostasis.
Grösgen S; Grimm MO; Friess P; Hartmann T
Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
[TBL] [Abstract][Full Text] [Related]
20. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.
Muratore CR; Rice HC; Srikanth P; Callahan DG; Shin T; Benjamin LN; Walsh DM; Selkoe DJ; Young-Pearse TL
Hum Mol Genet; 2014 Jul; 23(13):3523-36. PubMed ID: 24524897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
